Barry Galitzer, MD
Dermatology · Ft Lauderdale, FLNPI 1437243888
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Biofrontera Inc. accounts for 71.0% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $2,585 and has fallen 88.2% since, to $305 in 2025.
Across 38 payments — averaging $88.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biofrontera Inc.$2K
- Merz North America, Inc.$419
- AbbVie$135
- Johnson & Johnson$100
- Sanofi$74
- Novartis$74
- plus $173 from 5 others
Across 5 payments — averaging $9140.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biofrontera Inc.$46K
What the payments were for
- Speaking & faculty fees$2,00059%
- Travel & lodging$231%
- Food & beverage$1,34440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biofrontera Inc. | 10 | $2,391 |
| Merz North America, Inc. | 2 | $419 |
| AbbVie(2 entities) | 9 | $135 |
| Johnson & Johnson | 4 | $100 |
| Sanofi | 3 | $74 |
| Novartis | 3 | $74 |
| Galderma Laboratories, L.p. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Amgen | 1 | $33 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMELUZ$2,125
- BF-RhodoLED$2,125
- XEPI$2,125
How this compares
$3,367 in reported general payments places this provider in the 55th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 182 | $9,369 |
| Hydrocortisone | 611 | $4,123 |
| Triamcinolone Acetonide | 418 | $4,113 |
| Ketoconazole | 89 | $2,339 |
| Mometasone Furoate | 87 | $1,906 |
| Fluocinolone Acetonide Oil | 29 | $1,250 |
| ValacyclovirValacyclovir Hcl | 77 | $937 |
| Fluorouracil | 17 | $725 |
| Mupirocin | 88 | $651 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $570 |
| Betamethasone Dipropionate | 14 | $486 |
| Clindamycin Phos-Benzoyl PeroxClindamycin Phos/Benzoyl Perox | 22 | $468 |
| Doxycycline Hyclate | 20 | $356 |
| Minoxidil | 16 | $241 |
| Cephalexin | 33 | $201 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Ft Lauderdale
- Shino Bay AguileraFt Lauderdale$1M
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.